中脑腹侧被盖区多巴胺能神经元的异质性

中脑腹侧被盖区(ventral tegmental area,VTA)多巴胺能神经元作为中脑多巴胺奖赏系统的重要组成成分,参与多种生理和病理过程如正性和负性(奖赏、厌恶等)的情感体验和应答、抑郁、和慢性疼痛等。近年研究发现VTA多巴胺能神经元在介导这些生理和病理过程中表现出显著的异质性,体现在其不同的投射靶区和同种神经元对不同刺激在应答上存在差异。本文对该领域的近期研究进行综述,详细了解这些差异可能为针对性的干预研究提供思路。     

运动奖赏效应及其神经生物学机制的研究进展

身体活动不足已经成为当今社会的公共卫生问题。深入理解运动的奖赏效应及其可能的神经生物学机制,将为改善身体活动不足提供科学有效的干预靶点。本文指出运动是一种典型的自然奖赏行为。大脑奖赏相关的腹侧背盖区-伏隔核的多巴胺能神经环路、前额叶皮质-伏隔核的谷氨酸能神经投射、红核-腹侧背盖区的谷氨酸能神经投射是调控运动奖赏效应的关键神经环路机制。此外,多巴胺、内源性大麻素系统和内源性阿片肽等多种神经分子参与了运动奖赏效应的调控。然而,大脑奖赏系统的过度激活将会导致运动成瘾。     

单次注射人工合成大麻素降低大鼠中脑腹侧背盖区多巴胺能神经元兴奋性北大核心CSCD

大麻成瘾可能维持一生。中脑腹侧背盖区(ventral tegmental area,VTA)作为投射到意识及情绪相关皮层和边缘系统的多巴胺能神经元的主要来源,是奖赏系统的关键部位之一,与药物成瘾密切相关。目前,对于VTA多巴胺能神经元在药物成瘾过程中的作用研究,主要集中在药物成瘾过程中突触可塑性的变化。已有研究表明,大麻素慢性作用5天后,易化了低频电刺激诱导VTA多巴胺能神经元产生突触传递的长时程减弱(long-term depression,LTD)效应,而此过程中多巴胺能神经元兴奋性的变化情况还未见报道。实验中,作者采用离体脑片膜片钳技术,观察单次注射人工合成大麻素HU210对大鼠VTA区多巴胺能神经元兴奋性的影响。结果显示,HU210作用后,神经元基强度增大,平均放电频率降低,其细胞膜电生理特性也发生了改变,表明单次注射人工合成大麻素HU210,降低了VTA多巴胺能神经元的兴奋性,提示神经元内在兴奋性的可塑性改变可能在药物成瘾中发挥作用。     

多巴胺的负调控中枢——缰核在抑郁症中的作用

腹侧被盖区(VTA)在大脑奖赏环路中起到核心调控作用。抑郁症中VTA的多巴胺能神经元电活动发生异常改变。近年来的研究发现,来自缰核的输入能够负调控VTA多巴胺神经元的电活动。在抑郁动物模型中,由于βCaMKII表达水平异常增加所引起的被过度活化的外侧缰核神经元,可以通过降低包括多巴胺在内的单胺水平,最终导致多种核心抑郁表型的产生。     

慢性神经痛对抑郁状态以及中枢多巴胺神经元电生理的影响

目的：探讨大鼠慢性神经痛导致抑郁症状发生后,中脑腹侧被盖区多巴胺能神经元自发放电活动的改变情况。方法：24只健康成年大鼠进行随机分组（n=12）：假手术组（Sham）大鼠仅进行坐骨神经分支暴露,坐骨神经损伤组（SNI）进行坐骨神经分支选择性损伤。在神经损伤后的第3、7、14、28、42、56天进行机械刺激计算缩足反射阈值,并进行糖水偏好、强迫游泳、旷场实验等行为学实验来评价大鼠是否发生抑郁症状;利用在体多通道电生理技术,对SNI组大鼠和假手术组大鼠中脑腹侧被盖区神经元分别进行记录分析。结果：与假手术组比较,SNI组大鼠的机械痛阈值明显降低（P<0.01）;在旷场实验、糖水偏好、强迫游泳较对照组出现显著性差异（P<0.01）;大鼠中脑腹侧被盖区多巴胺能神经元自发放电频率、簇状放电活动中动作电位的数量明显增加（P<0.01）。结论：慢性疼痛可以导致大鼠抑郁相关症状的发生,中脑腹侧被盖区多巴胺能神经元自发放电频率增加与疼痛后抑郁发生相关。     

L-谷氨酸和卡巴胆碱对中脑腹侧被盖区多巴胺能神经元簇放电的影响

中脑腹侧被盖区(ventral tegmental area,VTA)多巴胺能神经元的簇放电会导致其突触末梢多巴胺释放量瞬时大量增加,已被公认是编码奖赏效应的功能相关信号,但诱发多巴胺能神经元产生簇放电的神经调节的具体机制尚不完全清楚。为深入理解诱发VTA多巴胺能神经元产生簇放电介导奖赏信号的递质机制和不同脑区间的协同作用,本实验利用大鼠离体脑片,研究了胆碱能受体激动剂卡巴胆碱单独灌流,兴奋性谷氨酸能受体激动剂L-谷氨酸单独脉冲式给药及二者同时作用时VTA多巴胺能神经元簇放电的产生。结果显示,在离体脑片,卡巴胆碱(10μmol/L)持续灌流或L-谷氨酸(3mmol/L)脉冲式给药均能够诱发多巴胺能神经元产生簇放电。在二者单独作用不能诱发簇放电的神经元,卡巴胆碱和谷氨酸联合用药则可以诱发出簇放电。这些结果提示,卡巴胆碱和L-谷氨酸在诱发多巴胺能神经元簇放电的过程中具有协同作用。     

核受体相关因子1的研究进展

核受体相关因子 1(nuclearreceptor relatedfactor 1,Nurr1)是一种转录因子 ,属于核受体超家族成员 ,主要表达于中脑黑质与腹侧被盖区 ,作为基因转录调控蛋白而参与了中脑多巴胺能神经元的发育与存活、长时记忆、肝再生及炎症等多种生理和病理过程。本文总结和讨论了有关Nurr1的编码基因、分子结构、组织表达及生物学功能等方面研究的新近进展     

中脑多巴胺神经元位相性兴奋与行为强化

生理状态下,突然呈现的奖赏刺激可以诱发机体中脑多巴胺能神经元产生位相性兴奋。近期有研究认为,这种位相性兴奋直接反映了机体对奖赏的预期与实际奖赏间的差异,而此兴奋所导致的多巴胺释放可显著改变多巴胺能神经支配区域多巴胺的浓度,影响纹状体及其它边缘皮层区神经元的兴奋性,并介导神经突触效能发生长时程改变。经此方式,奖赏相关的环境变化对机体的行为产生即时和长期影响,这一过程可能是自然奖赏物及成瘾药物产生行为强化效应的基础之一。     

天然奖赏与药物奖赏

动物和人的中枢神经系统具有奖赏机制来加强和激励对机体有益的行为,以利个体生存和种族繁衍。但这一系统一旦被某些外源性物质反复地异常激活(如药物滥用),则引起神经系统的慢性适应性改变,将对机体造成严重损害。实现奖赏效应的神经结构主要位于中脑边缘系统,中脑腹侧被盖区(VTA)至伏核(NAc)的多巴胺通路是食物和性活动等天然奖赏和成瘾性药物引起奖赏效应的共同通路。本文概述天然奖赏和成瘾性药物奖赏的异同,旨在探讨阻断后者而不损及前者的途径。     

缺乏多巴胺D2受体的小鼠不表现阿片奖赏效应

经典观念认为药物滥用时的行为反应由起于腹侧被盖区（ＶＴＡ）并投射到边缘系统的中脑边缘多巴能通路介导。１９９７年,法国ＲｅｎｅＤｅｓｃａｒｔｅｓ大学ＲａｆａｅｌＭａｌｄｏｎａｄｏ研究小组进行了一系列实验研究,说明多巴胺Ｄ２受体参与了药物滥用时的行为反...     

Central mechanisms of roles of taste in reward and eating

Taste is unique among sensory systems in its innate association with mechanisms of reward and aversion in addition to its recognition of quality, e.g., sucrose is sweet and preferable, and quinine is bitter and aversive. Taste information is sent to the reward system and feeding center via the prefrontal cortices such as the mediodorsal and ventrolateral prefrontal cortices in rodents and the orbitofrontal cortex in primates. The amygdala, which receives taste inputs, also influences reward and feeding. In terms of neuroactive substances, palatability is closely related to benzodiazepine derivatives and beta-endorphin, both of which facilitate consumption of food and fluid. The reward system contains the ventral tegmental area, nucleus accumbens and ventral pallidum and finally sends information to the lateral hypothalamic area, the feeding center. The dopaminergic system originating from the ventral tegmental area mediates the motivation to consume palatable food. The actual ingestive behavior is promoted by the orexigenic neuropeptides from the hypothalamus. Even palatable food can become aversive and avoided as a consequence of a postingestional unpleasant experience such as malaise. The neural mechanisms of this conditioned taste aversion will also be elucidated.     

Conditional Knockout of NMDA Receptors in Dopamine Neurons Prevents Nicotine-Conditioned Place Preference

Nicotine from smoking tobacco produces one of the most common forms of addictive behavior and has major societal and health consequences. It is known that nicotine triggers tobacco addiction by activating nicotine acetylcholine receptors (nAChRs) in the midbrain dopaminergic reward system, primarily via the ventral tegmental area. Heterogeneity of cell populations in the region has made it difficult for pharmacology-based analyses to precisely assess the functional significance of glutamatergic inputs to dopamine neurons in nicotine addiction. By generating dopamine neuron-specific NR1 knockout mice using cre/loxP-mediated method, we demonstrate that genetic inactivation of the NMDA receptors in ventral tegmental area dopamine neurons selectively prevents nicotine-conditioned place preference. Interestingly, the mutant mice exhibit normal performances in the conditioned place aversion induced by aversive air puffs. Therefore, this selective effect on addictive drug-induced reinforcement behavior suggests that NMDA receptors in the dopamine neurons are critical for the development of nicotine addiction.     

Absolute coding of stimulus novelty in the human substantia nigra/VTA

Novelty exploration can enhance hippocampal plasticity in animals through dopaminergic neuromodulation arising in the substantia nigra/ventral tegmental area (SN/VTA). This enhancement can outlast the exploration phase by several minutes. Currently, little is known about dopaminergic novelty processing and its relationship to hippocampal function in humans. In two functional magnetic resonance imaging (fMRI) studies, SN/VTA activations in humans were indeed driven by stimulus novelty rather than other forms of stimulus salience such as rareness, negative emotional valence, or targetness of familiar stimuli, whereas hippocampal responses were less selective. SN/VTA novelty responses were scaled according to absolute rather than relative novelty in a given context, unlike adaptive SN/VTA responses recently reported for reward outcome in animal studies. Finally, novelty enhanced learning and perirhinal/parahippocampal processing of familiar items presented in the same context. Thus, the human SN/VTA can code absolute stimulus novelty and might contribute to enhancing learning in the context of novelty.     

Intra-accumbal Cannabinoid Agonist Attenuated Reinstatement but not Extinction Period of Morphine-Induced Conditioned Place Preference; Evidence for Different Characteristics of Extinction Period and Reinstatement

Neurochemical Research - The brain reward system consists of the ventral tegmental area that sends its dopaminergic projections to the forebrain, cortical areas, amygdala and largely to the nucleus...     

Receptors in the Ventral Tegmental Area Mediating Nicotine-Induced Dopamine Release in the Nucleus Accumbens

Nicotine or cocaine, when administered intravenously, induces an increase of extracellular dopamine in the nucleus accumbens. The nicotine-mediated increase was shown to occur at least in part through increase of the activity of dopamine neurons in the ventral tegmental area. As part of our continuing studies of the mechanisms of nicotine effects in the brain, in particular, effects on reward and cognitive mechanisms, in the present study we examined the role of various receptors in the ventral tegmental area in nicotine and cocaine reward. We assayed inhibition of the increase of dopamine in the nucleus accumbens induced by intravenous nicotine or cocaine administration by antagonists administered into the ventral tegmental area. Nicotine-induced increase of accumbal dopamine release was inhibited by intrategmental nicotinic (mecamylamine), muscarinic (atropine), dopaminergic (D₁: SCH 23390, D₂: eticlopride), and NMDA glutamatergic (MK 801) and GABA_B (saclofen) antagonists, but not by AMPA-kainate (CNQX, GYKI-52466) antagonists under our experimental circumstances. The intravenous cocaine-induced increase of dopamine in the nucleus accumbens was inhibited by muscarinic (atropine), dopamine 2 (eticlopride), and GABA_B (saclofen) antagonists but not by antagonists to nicotinic (mecamylamine), dopamine D₁ (SCH 23390), glutamate (MK 801), or AMPA-kainate (CNQX, GYKI-52466) receptors. Antagonists administered in the ventral tegmental area in the present study had somewhat different effects when they were previously administered intravenously. When administered intravenously atropine did not inhibit cocaine effects. The inhibition by atropine may be indirect, since this compound, when administered intrategmentally, decreased basal dopamine levels in the accumbens. The findings indicate that a number of receptors in the ventral tegmental area mediate nicotine-induced dopamine changes in the nucleus accumbens, a major component of the nicotine reward mechanism. Some, but not all, of these receptors in the ventral tegmental area also seem to participate in the reward mechanism of cocaine. The importance of local receptors in the ventral tegmental area was further indicated by the increase in accumbal dopamine levels after intrategmental administration of nicotine or also cocaine.     

Central integration of cardiovascular and drinking responses elicited by central administration of angiotensin II: divergence of regulation by the ventral tegmental area and nucleus accumbens

Previous studies had implicated the involvement of the ventral tegmental area and its dopamine projections to the nucleus accumbens in goal-directed behavior. This study investigated whether or not the GABAergic inputs to the ventral tegmental area and, in turn, dopaminergic input to the nucleus accumbens from the ventral tegmental area modify drinking and cardiovascular responses elicited by central administration of angiotensin II. Injections of 25 ng of angiotensin II into a lateral cerebral ventricle of the rat elicited water intakes averaging 7-8 mL in 15 min with latencies usually less than 3 min. Pretreatment of the nucleus accumbens with spiperone, a dopamine antagonist, or the ventral tegmental area with gamma-amino butyric acid (GABA) produced dose-dependent reductions in water intake and number of laps taken while increasing the latency to drink. The spiperone injection did not alter the pressor response. On the other hand, the GABA injections attenuated the pressor responses to central angiotensin II administration. These findings suggest that GABA input to the ventral tegmental area modifies both the cardiovascular and drinking responses elicited following central administration of angiotensin II. However, the dopamine projections to the nucleus accumbens appear to be involved only in the drinking responses elicited by central injections of angiotensin II. Divergence for the coordination of the skeletal motor behavioral component and the cardiovascular component elicited by central administration of angiotensin II must occur before the involvement of these dopamine pathways.     

Identifying the neural circuitry of alcohol craving and relapse vulnerability

With no further intervention, relapse rates in detoxified alcoholics are high and usually exceed 80% of all detoxified patients. It has been suggested that stress and exposure to priming doses of alcohol and to alcohol-associated stimuli (cues) contribute to the relapse risk after detoxification. This article focuses on neuronal correlates of cue responses in detoxified alcoholics. Current brain imaging studies indicate that dysfunction of dopaminergic, glutamatergic and opioidergic neurotransmission in the brain reward system (ventral striatum including the nucleus accumbens) can be associated with alcohol craving and functional brain activation in neuronal systems that process attentional relevant stimuli, reward expectancy and experience. Increased functional brain activation elicited by such alcohol-associated cues predicted an increased relapse risk, whereas high brain activity elicited by affectively positive stimuli may represent a protective factor and was correlated with a decreased prospective relapse risk. These findings are discussed with respect to psychotherapeutic and pharmacological treatment options.     

New perspectives on cocaine addiction: recent findings from animal research

Research with laboratory animals has provided several insights into the nature of cocaine abuse and addiction. First, the nature of drug addiction has been reevaluated and the emphasis has shifted from physical dependence to compulsive drug-taking behavior. Second, animal studies suggest that cocaine is at least as addictive as heroin and possibly even more addictive. Third, cocaine is potentially more dangerous than heroin as evidenced by the higher fatality rate seen in laboratory animals given unlimited access to these drugs. Fourth, the neural basis of cocaine reinforcement has been identified and involves an enhancement of dopaminergic neurotransmission in the ventral tegmental dopamine system. Other addictive drugs (e.g., opiates) may also derive at least part of their reinforcing impact by pharmacologically activating this reward system. Fifth, although the biological consequences of repeated cocaine self-administration on central nervous system functioning are poorly understood, preliminary findings suggest that intravenous cocaine self-administration may decrease neural functioning in this brain reward system. This has important clinical implications because diminished functioning of an important brain reward system may significantly contribute to relapse into cocaine addiction. These and other findings from experimentation with laboratory animals suggest new considerations for the etiology and treatment of drug addiction.     

Lesions of the Fasciculus Retroflexus Alter Footshock-Induced cFos Expression in the Mesopontine Rostromedial Tegmental Area of Rats

Midbrain dopamine neurons are an essential part of the circuitry underlying motivation and reinforcement. They are activated by rewards or reward-predicting cues and inhibited by reward omission. The lateral habenula (lHb), an epithalamic structure that forms reciprocal connections with midbrain dopamine neurons, shows the opposite response being activated by reward omission or aversive stimuli and inhibited by reward-predicting cues. It has been hypothesized that habenular input to midbrain dopamine neurons is conveyed via a feedforward inhibitory pathway involving the GABAergic mesopontine rostromedial tegmental area. Here, we show that exposing rats to low-intensity footshock (four, 0.5 mA shocks over 20 min) induces cFos expression in the rostromedial tegmental area and that this effect is prevented by lesions of the fasciculus retroflexus, the principal output pathway of the habenula. cFos expression is also observed in the medial portion of the lateral habenula, an area that receives dense DA innervation via the fr and the paraventricular nucleus of the thalamus, a stress sensitive area that also receives dopaminergic input. High-intensity footshock (120, 0.8 mA shocks over 40 min) also elevates cFos expression in the rostromedial tegmental area, medial and lateral aspects of the lateral habenula and the paraventricular thalamus. In contrast to low-intensity footshock, increases in cFos expression within the rostromedial tegmental area are not altered by fr lesions suggesting a role for non-habenular inputs during exposure to highly aversive stimuli. These data confirm the involvement of the lateral habenula in modulating the activity of rostromedial tegmental area neurons in response to mild aversive stimuli and suggest that dopamine input may contribute to footshock- induced activation of cFos expression in the lateral habenula.